About
Kopra develops cancer immunotherapies that engineer cancer cells to act as biofactories, triggering their own destruction.
Explore Kopra's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.
Kopra develops cancer immunotherapies that engineer cancer cells to act as biofactories, triggering their own destruction.
Funding rounds, investor list, and risk signals — unlock with a subscription.